Thomas B. Wiegmann

7.1k citations
73 papers · 5.5k · 2 hit papers · h-index 26

Impact in

Papers in

    • Chronic Kidney Disease and Diabetes 13
    • Dialysis and Renal Disease Management 6
    • Parathyroid Disorders and Treatments 5
    • Acute Kidney Injury Research 4
    • Blood Pressure and Hypertension Studies 8

Thomas B. Wiegmann

64 papers receiving 5.2k citations

Thomas B. Wiegmann's Hit Papers

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial 2019 · 2.3k citations
2.3k0+2+4Years since publication50010001.5k2.0k

Peers

Thomas B. Wiegmann
Comparison fields: 5 of 123
  • Endocrinology, Diabetes and Metabolism 2.8k
  • Nephrology 1.1k
  • Cardiology and Cardiovascular Medicine 1.4k
  • Pharmacology 455
  • Surgery 813
Replace Stuart R. Warren with:
Stuart R. Warren United States
Branko Braam Canada
Aimun Ahmed United Kingdom
Honora H. McElroy United States
Rudy Bilous United Kingdom
Frans H.M. Derkx Netherlands
Markus Tölle Germany
Markus Peter Schneider Germany
Władysław Grzeszczak Poland
Ole Lederballe‐Pedersen United States
Thomas B. Wiegmann relative to Stuart R. Warren United States Stuart R. Warren's profile →
Citations per field
00.5×1.5×2.2×
Stuart R. Warren · 1×
Citations per year

Countries citing papers authored by Thomas B. Wiegmann

Since Specialization
Citations

This map shows the geographic impact of Thomas B. Wiegmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas B. Wiegmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas B. Wiegmann more than expected).

Fields of papers citing papers by Thomas B. Wiegmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas B. Wiegmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas B. Wiegmann. The network helps show where Thomas B. Wiegmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas B. Wiegmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas B. Wiegmann Line = papers co-authored together Thomas B. Wiegmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hit paper breakdown →
20192307
2
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hit paper breakdown →
2019492
3 2003324
4 2005302
5 2005259
6
Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
1994198
7 1983159
8 2011145
9 2017108
10 199283
11 199267
12 199058
13 202158
14 199357
15 201652
16 200451
17 200749
18 198747
19 199246
20
Technetium-99m-pyrophosphate bone scans in hyperparathyroidism.
197745

About Thomas B. Wiegmann

Thomas B. Wiegmann is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Emergency Medical Services and Endocrinology, Diabetes and Metabolism, having authored 73 papers that have together received 5.5k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (13 papers), Blood Pressure and Hypertension Studies (8 papers), Dialysis and Renal Disease Management (6 papers), Central Venous Catheters and Hemodialysis (5 papers), Parathyroid Disorders and Treatments (5 papers), Acute Kidney Injury Research (4 papers), Diabetes Treatment and Management (4 papers) and Pharmacology and Obesity Treatment (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.8k citations), Nephrology (1.1k citations), Cardiology and Cardiovascular Medicine (1.4k citations), Pharmacology (455 citations) and Surgery (813 citations). Thomas B. Wiegmann has collaborated with scholars based in United States, Germany and Israel. Frequent co-authors include Margaret L. MacDougall, Edmund J. Lewis, Lawrence G. Hunsicker, Julia Breyer Lewis, Dennis A. Diederich, Paul Drury, Francesco Locatelli, Itamar Raz, Virginia J. Savin and Tomás Berl. Their work appears in journals such as American Journal of Kidney Diseases, Journal of the American Society of Nephrology, Diabetes, Journal of Clinical Hypertension and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact